Moroz V, Wilson JS, Kearns P, Wheatley KComparison of anticipated and actual control group outcomes in randomised trials in paediatric oncology provides evidence that historically controlled studies are biased in favour of the novel treatment. Trials. 2014 Dec 10;15:481
Loke J, Khan JN, Wilson JS, Craddock C, Wheatley K. Mylotarg has potent anti-leukaemic effect: a systematic review and meta-analysis of anti-CD33 antibody treatment in acute myeloid leukaemia. Ann Hematol (online version of this article Ann Hematol. 2015 Mar;94(3):361-73 Ann Hematol (online version of this article (doi:10.1007/s00277-014-2218-6)
Wilson JS, Gains JE, Moroz V, Wheatley K, Gaze MN. A systematic review of 131I-meta iodobenzylguanidine molecular radiotherapy for neuroblastoma. Eur J Cancer 2014 Mar, 50(4):801-15. Epub 2013 Dec 12
Greenheld W, Wilson J, Bayliss S, Hyde C. The clinical and cost-effectiveness of intensive versus standard lipid lowering with statins in the prevention of cardiovascular events amongst patients with acute coronary syndromes: a systematic review. Report number 68, 2008, Department of Public Health and Epidemiology, University of Birmingham. ISBN 070442696X - 9780704426962
Wilson J, Wang D, Meads C. Simple interventions to prevent respiratory and gastrointestinal infection in children in day care and school settings – a systematic review and economic evaluation. Report number 57, 2006. Department of Public Health and Epidemiology, University of Birmingham. ISBN No: 0704426102-9780704426108.
Bohlius J, Wilson J, Seidenfeld J, Piper M, Schwarzer G, Sandercock J, Trelle S, Weingart O, Bayliss S, Djulbegovic B, Bennett CL, Langensiepen S, Hyde C, Engert A. Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients. Journal of National Cancer Institute 2006; 17; 98(10):708-14.
Wilson J, Yao GL, Raftery J, Bohlius J, Brunskill S, Sandercock J, Bayliss S, Moss P, Stanworth S, Hyde C. A systematic review and economic evaluation of epoetin alfa, epoetin beta and darbepoetin alfa in anaemia associated with cancer, especially that attributable to cancer treatment. Health Technology Assessment 2007; 11 (13): 1-202.
Wilson J, Connock M, Song F, Yao G, Fry-Smith A, Raftery J, Peake D. Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours: systematic review and economic evaluation. Health Technology Assessment 2005; 9(25):1-142.
Song FJ, Fry-Smith A, Davenport C, Bayliss S, Adi Y, Wilson JS, Hyde C. Identification and assessment of ongoing trials in health technology assessment reviews. Health Technology Assessment 2004; 8(44); 1-87.
Barton P, Jobanputra P, Wilson J, Bryan S, Burls A, The use of modelling to evaluate new drugs for patients with chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis. Health Technology Assess 2004; 8(11)
Jobanputra P, Wilson J, Douglas K, Burls A. A survey of British rheumatologists' DMARD preferences for rheumatoid arthritis. Rheumatology (Oxford). 2004 Feb;43(2):206-10.
Wilson J, Fry-Smith A, Goodwin J, Hawker J, Taylor R. A systematic review of the biological and health effects of exposure to cold temperature in healthy and diseased adults including the elderly. Department of Health 2002.
Wilson JS, Honey E, Templeton A, Paavonen J, Mardh PA, Stay-Pedersen B; EU Biomed Concerted Action Group. A systematic review of the prevalence of Chlamydia trachomatis among European women. Human Reprod Update 8(4);385-94 2002.